The Pharmacogenomics Journal
| Discipline | Pharmacogenomics |
|---|---|
| Language | English |
| Edited by | Julio Licinio |
| Publication details | |
| History | 2001-present |
| Publisher | |
| Frequency | Quarterly |
| 4.229 (2014) | |
| Standard abbreviations | |
| ISO 4 | Pharmacogenomics J. |
| Indexing | |
| CODEN | PJHOAZ |
| ISSN | 1470-269X (print) 1473-1150 (web) |
| LCCN | 2001243289 |
| OCLC no. | 49965587 |
| Links | |
The Pharmacogenomics Journal is a quarterly peer-reviewed medical journal covering pharmacogenomics. It was established in 2001 and is published by Nature Publishing Group. The editor-in-chief is Julio Licinio (State University of New York Upstate Medical University). According to the Journal Citation Reports, the journal had a 2014 impact factor of 4.229.[1]
References
- ^ "The Pharmacogenomics Journal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
External links
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |